Verapamil Heart Medication Approved – Analyzed
Zydus Lifesciences, a company that makes medicines, has just gotten the “green light” from the U.S. government to sell Verapamil, a drug used to treat high blood pressure. This means doctors and patients in America can now use this medicine to help prevent serious heart issues. It’s good news for people managing their heart health.
Key Points
- Zydus Lifesciences gained FDA approval for Verapamil tablets.
- Verapamil lowers blood pressure, reducing heart attack risks.
- 120mg, 180mg, and 240mg dosages available for patient needs.
- Annual US sales reached $24.5 million (IQVIA data, Sept-2025).
- Production will occur at Zydus Lifesciences facility in India.
- This expands treatment options for managing cardiovascular health.
About the Drug
Verapamil is a medicine that helps lower high blood pressure. High blood pressure can make your heart work harder and increase the risk of things like strokes and heart attacks. It does this by relaxing the blood vessels, making it easier for your heart to pump blood.
Sales and Production
Before this approval, Verapamil tablets had already been selling well in the United States. IQVIA data shows they made $24.5 million in sales over the last nine months (September 2025). Zydus Lifesciences will be making these tablets at their factory in Baddi, Himachal Pradesh, India.
This FDA approval represents a significant opportunity for Zydus Lifesciences and improved patient outcomes.
